Skip to content
healthcare.dev
Get a free key

Mary Kay Foundation Primer

NDC 51531-0850, avobenzone, homosalate, octisalate, octocrylene, gel, from Mary Kay Inc..

Product NDC
51531-0850
Status
Listed
Labeler
Mary Kay Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51531-0850 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AVOBENZONE2.5 g/100mL
  • HOMOSALATE9 g/100mL
  • OCTISALATE5 g/100mL
  • OCTOCRYLENE3 g/100mL
Package NDCNDC-11Package
51531-0850-051531085000.5 mL in 1 PACKET (51531-0850-0)
51531-0850-1515310850011 TUBE in 1 CARTON (51531-0850-1) / 29 mL in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51531-0850 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51531-0850 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51531-0850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.